Grimes & Company’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.55M Buy
18,880
+1,787
+10% +$380K 0.08% 149
2026
Q2
$3.57M Buy
17,093
+5,459
+47% +$1.08M 0.08% 157
2026
Q1
$1.91M Buy
11,634
+8,759
+305% +$1.52M 0.05% 187
2025
Q4
$510K Buy
2,875
+104
+4% +$17.3K 0.01% 307
2025
Q3
$441K Sell
2,771
-122
-4% -$18K 0.01% 326
2025
Q2
$407K Buy
2,893
+767
+36% +$94.2K 0.01% 296
2025
Q1
$248K Buy
2,126
+410
+24% +$52.8K 0.01% 315
2024
Q4
$216K Buy
+1,716
New +$211K 0.01% 356

Other funds holding MS

Grimes & Company's MS Position: Q3 2026 in Review

Grimes & Company increased its Morgan Stanley (MS) stake by 10% in Q3 2026, buying an estimated $380K and bringing the position to 18,880 shares worth $3.55M. The position accounts for 0.08% of the portfolio, ranked #149.

Grimes & Company first reported a position in MS in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.57M in Q2 2026. 1,613 funds tracked by Wall St. Rank hold MS as of Q3 2026.

  • Grimes & Company held 18,880 shares of Morgan Stanley worth $3.55M as of Q3 2026.
  • Grimes & Company bought 1,787 Morgan Stanley shares in Q3 2026, an estimated $380K.
  • Morgan Stanley made up 0.08% of Grimes & Company's portfolio in Q3 2026, its #149 holding.
  • Grimes & Company first reported a position in Morgan Stanley in Q4 2024 and has held it in 8 quarters since.
  • Grimes & Company's Morgan Stanley position peaked at $3.57M in Q2 2026.
  • 1,613 funds tracked by Wall St. Rank held Morgan Stanley as of Q3 2026.

Based on Grimes & Company's 13F filing for Q3 2026, filed 29 Oct 2026.